| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.51 | 0.009 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.51 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |